MPT — MEDICAL PPTYS TRUST INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying MPT?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their MPT position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).
- +5 tracked investors reported holding MPT at their latest filing
- +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
- −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.
About MEDICAL PPTYS TRUST INC (MPT)
MEDICAL PPTYS TRUST INC (MPT) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Philippe Laffont (Coatue Management), valued at $46M. Across recent filings, tracked investors recorded 4 new positions, 1 increased, 4 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in MPT
How many top investors track MPT
A small number of top investors own this.
MPT Ownership Composition
How MEDICAL PPTYS TRUST INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant57.7%
- Growth & Innovation33.8%
- Macro8.5%
Tracked investors currently reporting MPT
- Philippe LaffontJun 30, 2026Coatue ManagementShares4.5MValue$20.9M% Portfolio0.04%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares3.8MValue$17.7M% Portfolio0.00%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares3.9MValue$17.9M% Portfolio0.01%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares1MValue$4.8M% Portfolio0.01%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares89.1KValue$411.8K% Portfolio0.00%
Recent activity
- $17.1MMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- New$448KMay 15, 2026
- Reduced$411.8K(-7.89%)Aug 14, 2026
- Reduced$18.7M(-41.58%)May 15, 2024
- Reduced$10.9M(-36.52%)Aug 14, 2024
- Unchanged$14.8M(0.00%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $20MMay 15, 2025
- Increased$39M(172.71%)Aug 14, 2025
- Unchanged$45.9M(0.00%)Nov 14, 2025
- Reduced$22.6M(-50.00%)May 15, 2026
- Unchanged$21M(0.00%)May 15, 2026
- Unchanged$20.9M(0.00%)Aug 14, 2026
- $33.4MFeb 14, 2024
Frequently asked questions
- How many institutional investors hold MPT?
- 5 tracked institutional investors disclosed a position in MPT (MEDICAL PPTYS TRUST INC) in their most recent 13F filing.
- Who is the largest institutional holder of MPT?
- Philippe Laffont, Coatue Management, holds the largest disclosed position in MPT, valued at $46M.
- Did institutional ownership of MPT increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 1 increased, 4 reduced, and 2 fully exited MPT.
- Where does this MPT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.